中國人壽(601628.SH)2021年度淨利潤509.21億元 擬每股派0.65元
格隆匯3月24日丨中國人壽(601628.SH)發佈2021年年度報吿,實現營業收入8585.05億元,同比增長4.1%;營業利潤509.81億元,同比下降7.1%;歸屬於母公司股東的淨利潤509.21億元,同比增長1.3%;扣除非經常性損益後歸屬於母公司股東的淨利潤511.86億元,同比增長1.4%;每股收益1.80元,擬向全體股東派發現金股利每股人民幣0.65元(含税),共計約人民幣183.72億元。
2021年,公司保費收入達6183.27億元,同比增長1.0%;續期保費達4424.63億元,同比增長5.8%。截至報吿期末,內含價值達12030.08億元,較2020年底增長12.2%。受疫情和保險需求釋放趨緩等因素的影響,新單保費為1758.64億元,同比下降9.3%。首年期交保費為984.10億元,同比下降14.7%,其中,十年期及以上首年期交保費為416.82億元,同比下降26.1%。2021年,公司一年新業務價值為447.80億元,同比下降23.3%。長險有效保單數量達3.23億份,較2020年底增長1.9%。退保率為1.20%,同比上升0.11個百分點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.